Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | PLG | P00747 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14322259 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL28064250 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL20767099 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL4758861 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL1442288 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL27467045 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL2030994 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL7438483 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL7250811 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 | |
| SCHEMBL10785185 | 0.97 | LMNA (0.56) | NFKB1CYP2D6BLMLMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190214145-A1 | Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen | KUREK ITZHAK (US) | 2019-07-11 | — | — | US | disclosed |
| US-8748130-B2 | Human papillomavirus / Ii-Key hybrids and methods of use | ANTIGEN EXPRESS, INC. (US) | 2014-06-10 | — | — | US | disclosed |
| EP-2376622-A2 | GREEN PROCESS AND COMPOSITIONS FOR PRODUCING POLY(5HV) AND 5 CARBON CHEMICALS | Metalbolix Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| EP-2344191-A1 | HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE | Antigen Express, Inc. (US) | 2011-07-20 | — | — | EP | disclosed |
| WO-2010068953-A2 | GREEN PROCESS AND COMPOSITIONS FOR PRODUCING POLY(5HV) AND 5 CARBON CHEMICALS | METABOLIX INC. (US) | 2010-06-17 | — | — | WO | disclosed |
| US-20100080817-A1 | HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE | NUGENEREX IMMUNO-ONCOLOGY, INC. | 2010-04-01 | — | — | US | disclosed |
| WO-2010027973-A1 | HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE | ANTIGEN EXPRESS, INC. (US) | 2010-03-11 | — | — | WO | disclosed |